Recent Updates
Recently added Catalysts
CERS Positive Sentiment

Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

Wednesday, October 14, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Cerus Corporation will host a workshop at the 2026 AABB Annual Meeting in Atlanta, focusing on the implementation of INTERCEPT Platelets and INTERCEPT Fibrinogen Complex. The meeting is scheduled from October 17 to October 19 and will gather healthcare professionals and scientists to discuss advancements in blood and biotherapies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Cerus Corporation is actively engaging with the healthcare community.
  • The workshop will focus on real-world applications of their products.
  • The event will attract a diverse group of professionals and experts.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~61 mo
Minimal dilution risk
Lead asset
S303 Red Blood Cells
Phase 3 · Focus:Use of S303 RBCs in Patients With Acute Anemia

Full Press Release Details

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex, or IFC*, at the 2026 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting, taking place in Atlanta, Georgia from October 17 through October 19. The AABB Annual Meeting attracts healthcare professionals, scientists, and other experts from aroun

Frequently Asked Questions

What is the focus of the Cerus workshop?

The workshop will focus on the implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex.

When is the AABB Annual Meeting scheduled?

The AABB Annual Meeting will take place from October 17 to October 19, 2026.

Where will the AABB Annual Meeting be held?

The meeting will be held in Atlanta, Georgia.

Who will attend the AABB Annual Meeting?

The event will attract healthcare professionals, scientists, and other experts.

ShareAdd on Google
Tags: CERS Cerus Corporation AABB Annual Meeting INTERCEPT Platelets INTERCEPT Fibrinogen Complex Atlanta
Last updated: Oct 14, 2026

Biotech snapshot

Cash runway
$56M liquidity · $1M/mo burn
~61 mo
Minimal dilution risk
Lead asset
S303 Red Blood CellsPhase 3
Focus:Use of S303 RBCs in Patients With Acute Anemia →